Research Topic: non-alcoholic fatty liver disease

The Role of Nutraceuticals and Probiotics in Addition to Lifestyle Intervention in the Management of Childhood Obesity—Part 1: Metabolic Changes

mycolabadmin

This review examines how natural compounds and beneficial bacteria can help obese children improve their metabolic health when combined with diet and exercise changes. Key findings show that supplements like white mulberry leaf extract and special fiber products can help reduce weight, improve blood sugar control, and lower cholesterol. The evidence suggests these natural interventions are promising but need more large-scale studies in children to confirm their effectiveness and optimal dosing.

Read More »

Characterization of the gut mycobiome in patients with non-alcoholic fatty liver disease and correlations with serum metabolome

mycolabadmin

This study examined fungi in the gut of people with fatty liver disease and found that certain fungal species are more common in diseased patients. By analyzing both gut fungi and blood chemicals, researchers discovered that fungi significantly influence metabolic substances related to liver health. A computer model combining information about gut fungi and bacteria could identify fatty liver disease with reasonable accuracy, suggesting that fungi could be useful for disease diagnosis and potential treatment.

Read More »
Scroll to Top